US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 19.870
  • -0.040-0.20%
Close Aug 16 16:00 ET
  • 19.870
  • 0.0000.00%
Post 20:01 ET
2.36BMarket Cap35.48P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
23.23%122.71M
15.40%98.51M
85.90%398.2M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
52.10%214.2M
58.60%60.76M
59.21%57.24M
Operating revenue
23.23%122.71M
15.40%98.51M
85.90%398.2M
81.98%110.57M
79.39%102.69M
87.49%99.58M
98.12%85.37M
52.10%214.2M
58.60%60.76M
59.21%57.24M
Cost of revenue
27.90%15.41M
25.88%12.52M
51.10%51.97M
41.21%15.81M
46.58%14.17M
57.60%12.05M
68.86%9.95M
57.16%34.39M
52.35%11.2M
82.02%9.67M
Gross profit
22.58%107.31M
14.01%85.99M
92.56%346.24M
91.19%94.76M
86.05%88.52M
92.52%87.54M
102.75%75.42M
51.17%179.81M
60.08%49.56M
55.26%47.58M
Operating expense
29.93%53.06M
47.86%58.86M
232.72%259.43M
182.86%53.07M
459.28%125.71M
141.63%40.84M
100.73%39.81M
17.14%77.97M
2.97%18.76M
35.08%22.48M
Selling and administrative expenses
43.44%40.73M
57.94%46.94M
134.23%133.71M
198.38%42.04M
145.88%33.56M
119.82%28.4M
80.88%29.72M
15.03%57.09M
6.51%14.09M
12.31%13.65M
-Selling and marketing expense
43.33%26.25M
42.54%25.32M
194.17%86.69M
269.64%28.93M
185.88%21.68M
151.95%18.31M
161.62%17.76M
--29.47M
--7.83M
16.30%7.58M
-General and administrative expense
43.62%14.48M
80.83%21.62M
70.27%47.02M
109.30%13.1M
95.86%11.88M
78.48%10.08M
24.00%11.95M
--27.62M
--6.26M
7.69%6.07M
Research and development costs
-24.51%2.99M
-27.54%2.58M
370.72%93.15M
-51.82%1.97M
906.76%83.66M
-0.73%3.95M
4.67%3.56M
16.85%19.79M
-18.01%4.09M
85.20%8.31M
Depreciation amortization depletion
10.08%9.34M
43.07%9.34M
2,865.85%32.57M
1,461.90%9.06M
1,538.42%8.49M
--8.49M
--6.53M
--1.1M
--580K
--518K
-Depreciation and amortization
10.08%9.34M
43.07%9.34M
2,865.85%32.57M
1,461.90%9.06M
1,538.42%8.49M
--8.49M
--6.53M
--1.1M
--580K
--518K
Operating profit
16.16%54.25M
-23.82%27.13M
-14.75%86.81M
35.36%41.69M
-248.15%-37.19M
63.46%46.7M
105.05%35.61M
94.40%101.84M
141.73%30.8M
79.25%25.1M
Net non-operating interest income expense
109.82%3.8M
1.81M
Total other finance cost
-109.82%-3.8M
----
----
----
----
---1.81M
----
----
----
----
Other net income (expense)
-2.26M
15.20%1.96M
167.23%7.7M
127.23%5.02M
-192.04%-833K
1,732.26%1.7M
921.63%2.88M
3,008.45%2.21M
1,230.88%905K
Gain on sale of security
---2.26M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
15.20%1.96M
167.23%7.7M
127.23%5.02M
-192.04%-833K
----
1,732.26%1.7M
921.63%2.88M
3,008.45%2.21M
1,230.88%905K
Income before tax
15.00%55.79M
-22.04%29.09M
-9.75%94.51M
41.50%46.71M
-246.20%-38.02M
71.75%48.51M
113.72%37.31M
98.83%104.72M
157.61%33.01M
84.81%26.01M
Income tax
39.48%14.99M
-24.93%5.81M
6.75%23.1M
57.40%11.86M
-322.68%-7.26M
62.24%10.75M
83.62%7.75M
64.13%21.64M
115.10%7.54M
-12.93%3.26M
Net income
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
120.23%22.75M
Net income continuous Operations
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
120.23%22.75M
Minority interest income
Net income attributable to the parent company
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
120.23%22.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
8.03%40.79M
-21.28%23.28M
-14.05%71.41M
36.80%34.84M
-235.24%-30.76M
74.67%37.76M
123.31%29.57M
110.42%83.08M
173.62%25.47M
120.23%22.75M
Basic earnings per share
-2.78%0.35
-28.57%0.2
-16.25%0.67
37.50%0.33
-231.82%-0.29
71.43%0.36
115.38%0.28
110.53%0.8
166.67%0.24
120.00%0.22
Diluted earnings per share
0.00%0.33
-26.92%0.19
-16.00%0.63
40.91%0.31
-245.00%-0.29
65.00%0.33
116.67%0.26
102.70%0.75
144.44%0.22
100.00%0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 23.23%122.71M15.40%98.51M85.90%398.2M81.98%110.57M79.39%102.69M87.49%99.58M98.12%85.37M52.10%214.2M58.60%60.76M59.21%57.24M
Operating revenue 23.23%122.71M15.40%98.51M85.90%398.2M81.98%110.57M79.39%102.69M87.49%99.58M98.12%85.37M52.10%214.2M58.60%60.76M59.21%57.24M
Cost of revenue 27.90%15.41M25.88%12.52M51.10%51.97M41.21%15.81M46.58%14.17M57.60%12.05M68.86%9.95M57.16%34.39M52.35%11.2M82.02%9.67M
Gross profit 22.58%107.31M14.01%85.99M92.56%346.24M91.19%94.76M86.05%88.52M92.52%87.54M102.75%75.42M51.17%179.81M60.08%49.56M55.26%47.58M
Operating expense 29.93%53.06M47.86%58.86M232.72%259.43M182.86%53.07M459.28%125.71M141.63%40.84M100.73%39.81M17.14%77.97M2.97%18.76M35.08%22.48M
Selling and administrative expenses 43.44%40.73M57.94%46.94M134.23%133.71M198.38%42.04M145.88%33.56M119.82%28.4M80.88%29.72M15.03%57.09M6.51%14.09M12.31%13.65M
-Selling and marketing expense 43.33%26.25M42.54%25.32M194.17%86.69M269.64%28.93M185.88%21.68M151.95%18.31M161.62%17.76M--29.47M--7.83M16.30%7.58M
-General and administrative expense 43.62%14.48M80.83%21.62M70.27%47.02M109.30%13.1M95.86%11.88M78.48%10.08M24.00%11.95M--27.62M--6.26M7.69%6.07M
Research and development costs -24.51%2.99M-27.54%2.58M370.72%93.15M-51.82%1.97M906.76%83.66M-0.73%3.95M4.67%3.56M16.85%19.79M-18.01%4.09M85.20%8.31M
Depreciation amortization depletion 10.08%9.34M43.07%9.34M2,865.85%32.57M1,461.90%9.06M1,538.42%8.49M--8.49M--6.53M--1.1M--580K--518K
-Depreciation and amortization 10.08%9.34M43.07%9.34M2,865.85%32.57M1,461.90%9.06M1,538.42%8.49M--8.49M--6.53M--1.1M--580K--518K
Operating profit 16.16%54.25M-23.82%27.13M-14.75%86.81M35.36%41.69M-248.15%-37.19M63.46%46.7M105.05%35.61M94.40%101.84M141.73%30.8M79.25%25.1M
Net non-operating interest income expense 109.82%3.8M1.81M
Total other finance cost -109.82%-3.8M-------------------1.81M----------------
Other net income (expense) -2.26M15.20%1.96M167.23%7.7M127.23%5.02M-192.04%-833K1,732.26%1.7M921.63%2.88M3,008.45%2.21M1,230.88%905K
Gain on sale of security ---2.26M------------------------------------
Other non- operating income (expenses) ----15.20%1.96M167.23%7.7M127.23%5.02M-192.04%-833K----1,732.26%1.7M921.63%2.88M3,008.45%2.21M1,230.88%905K
Income before tax 15.00%55.79M-22.04%29.09M-9.75%94.51M41.50%46.71M-246.20%-38.02M71.75%48.51M113.72%37.31M98.83%104.72M157.61%33.01M84.81%26.01M
Income tax 39.48%14.99M-24.93%5.81M6.75%23.1M57.40%11.86M-322.68%-7.26M62.24%10.75M83.62%7.75M64.13%21.64M115.10%7.54M-12.93%3.26M
Net income 8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M120.23%22.75M
Net income continuous Operations 8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M120.23%22.75M
Minority interest income
Net income attributable to the parent company 8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M120.23%22.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 8.03%40.79M-21.28%23.28M-14.05%71.41M36.80%34.84M-235.24%-30.76M74.67%37.76M123.31%29.57M110.42%83.08M173.62%25.47M120.23%22.75M
Basic earnings per share -2.78%0.35-28.57%0.2-16.25%0.6737.50%0.33-231.82%-0.2971.43%0.36115.38%0.28110.53%0.8166.67%0.24120.00%0.22
Diluted earnings per share 0.00%0.33-26.92%0.19-16.00%0.6340.91%0.31-245.00%-0.2965.00%0.33116.67%0.26102.70%0.75144.44%0.22100.00%0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg